Ion-Channel-Targeting Drugs for Chikungunya Virus
Molecules · 01.10.2025 · 30 (19) · 3942
DOI: 10.3390/molecules30193942 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, online erschienen am 01.10.2025. Verfasst von Hiya Lahiri und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, J…. Hauptthemen laut MEDLINE: Chikungunya virus, Antiviral Agents, Ion Channels. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Israel Science Foundation, Foundation for the National Institutes of Health, United States-Israel Binational Agricultural Research and Development Fund.
Abstract (Originalsprache)
Alphaviruses are transmitted by Aedes mosquitoes and cause large-scale epidemics worldwide. Chikungunya virus (CHIKV) infection can cause febrile seizures known as chikungunya fever (CHIKF), which ultimately leads to severe joint pain and myalgia. While a vaccine has recently been introduced against CHIKV, at present, no anti-viral drug is available. CHIKV, like other alphaviruses, has a short 6K protein capable of forming an ion channel. Blocking this ion channel with drugs can therefore serve as a potential way to curtail CHIKV infection. To that end, we screened a repurposed drug library using three bacteria-based channel assays to detect blockers against 6K viroporin, yielding several hits. Interestingly, several of the blockers were able to inhibit the 6K protein from the similar Eastern equine encephalitis virus (EEEV), while others were not, pointing to structural specificity which may be explained by modeling studies. In conclusion, our study provides a starting point for developing a new route to potentially inhibit CHIKV.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Chemistry, The Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem, Edmond J. Safra Campus, Jerusalem 9190400, Israel.
- Department of Biomedical Engineering, City University of Hong Kong, Tat Chee Avenue, Kowloon, Hong Kong, China.
ORCID-Profile: Hiya Lahiri, Kingshuk Basu, Isaiah T Arkin
Förderung
- Israel Science Foundation
- Foundation for the National Institutes of Health
- United States-Israel Binational Agricultural Research and Development Fund
- The National Institutes of Health
- the Binational Agricultural Research and Development Fund
- startup fund from the City University of Hong Kong
Zitieren
APA
Lahiri, H., Basu, K., & Arkin, I. T. (2025). Ion-Channel-Targeting Drugs for Chikungunya Virus. Molecules, 30(19), 3942. https://doi.org/10.3390/molecules30193942
Vancouver
Lahiri H, Basu K, Arkin IT. Ion-Channel-Targeting Drugs for Chikungunya Virus. Molecules. 2025;30(19):3942. doi:10.3390/molecules30193942
BibTeX
@article{Lahiri2025,
author = {Lahiri, Hiya and Basu, Kingshuk and Arkin, Isaiah T},
title = {Ion-Channel-Targeting Drugs for Chikungunya Virus},
journal = {Molecules},
year = {2025},
volume = {30},
number = {19},
pages = {3942},
doi = {10.3390/molecules30193942}
}
EUVIMED